Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis
Original Article
E. Kastritis, G. Palladini, M.C. Minnema, A.D. Wechalekar, A. Jaccard, H.C. Lee, V. Sanchorawala, S. Gibbs, P. Mollee, C.P. Venner, J. Lu, S. Schönland, M.E. Gatt, K. Suzuki, K. Kim, M.T. Cibeira, M. Beksac, E. Libby, J. Valent, V. Hungria, S.W. Wong, M. Rosenzweig, N. Bumma, A. Huart, M.A. Dimopoulos, D. Bhutani, A.J. Waxman, S.A. Goodman, J.A. Zonder, S. Lam, K. Song, T. Hansen, S. Manier, W. Roeloffzen, K. Jamroziak, F. Kwok, C. Shimazaki, J.-S. Kim, E. Crusoe, T. Ahmadi, N. Tran, X. Qin, S.Y. Vasey, B. Tromp, J.M. Schecter, B.M. Weiss, S.H. Zhuang, J. Vermeulen, G. Merlini, and R.L. Comenzo
N Engl J Med 2021;385:46-58
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Course closed
This course closed on Saturday, July 1, 2023 - 11:59pm.